Similar articles

• [Use of artemether in the treatment of severe malaria, an alternative in an unusual situation].

  Nicolas X, Breton G, Le Bras M. Nicolas X, et al. Med Trop (Mars). 1997;57(1):96-7. Med Trop (Mars). 1997. PMID: 9289620 French. No abstract available.
• New combination drug to treat malaria.

  Das P. Das P. Lancet Infect Dis. 2005 May;5(5):267. doi: 10.1016/s1473-3099(05)70104-3. Lancet Infect Dis. 2005. PMID: 15889476 No abstract available.
• Short course of azithromycin/artesunate against falciparum malaria: no full protection against recrudescence.

  de Vries PI, Le NH, Le TD, Ho PL, Nguyen VN, Trinh KA, Kager PA. de Vries PI, et al. Trop Med Int Health. 1999 May;4(5):407-8. doi: 10.1046/j.1365-3156.1999.00412.x. Trop Med Int Health. 1999. PMID: 10402979 No abstract available.
• Progress in the research of artemisinin and its analogues as antimalarials: an update.

  Sriram D, Rao VS, Chandrasekhara KV, Yogeeswari P. Sriram D, et al. Nat Prod Res. 2004 Dec;18(6):503-27. doi: 10.1080/14786410310001620556. Nat Prod Res. 2004. PMID: 15595609 Review.
• [Severe falciparum malaria among travellers to Thailand. Blood exchange and artemisinine treatment are therapeutic alternatives].

  Ekvall H, Aust-Kettis A, Björkman A. Ekvall H, et al. Lakartidningen. 1997 Apr 30;94(18):1713-5. Lakartidningen. 1997. PMID: 9182179 Review. Swedish. No abstract available.